📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-13 14:21
232 analysed today
FollowTelegram
232
Today
149,633
All-time analysed
42,906
Positive
6,661
Negative
91,389
Neutral
8,609
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
23 announcements match the current filters (relevance ≥ 5).
DCM Shriram Industries Q1 Net Profit at ₹0.88 Cr; Revenue Grows 7.3% YoY to ₹293.63 Cr
DCM Shriram Industries reported a flat Net Profit of ₹0.88 Cr for Q1 FY27, matching the restated profit of the same quarter last year. Revenue from operations grew 7.3% YoY to ₹293.63 Cr, up from ₹273.54 Cr (restated). Following the completion of its Composite Scheme of Arrangement, the company now operates as a single-segment entity focused on Sugar and Distillery. The results reflect the new corporate structure after the demerger of the Chemical and Rayon businesses.
Confidence: HIGH
What changedThe company has completed its demerger of Chemical and Rayon businesses, resulting in restated financials and a shift to a single-segment reporting structure (Sugar/Distillery).
Why it mattersThe business is now highly concentrated in the cyclical and regulated sugar industry, removing the diversification previously provided by the chemical and rayon segments.
Revenue (Q1 FY27): ₹293.63 CrNet Profit (Q1 FY27): ₹0.88 CrYoY Revenue Growth: 7.3%Q1 Revenue vs TTM Revenue: ~28.5%EPS (Q1 FY27): ₹0.10
📅 Short termThe stock is likely to remain range-bound as the market digests the flat profit performance and the simplified business structure post-demerger.
📈 Long termLong-term performance will be dictated by the sugar cycle and government ethanol policies; the company's ability to optimize its integrated sugar-power-alcohol model is now the sole value driver.
⚠ Risk flags
- High sector concentration risk in Sugar/Distillery
- Regulatory risk regarding sugar prices and ethanol quotas
- Ongoing sub-judice GST/VAT litigation in Uttar Pradesh
Key Highlights
Revenue from operations increased 7.3% YoY to ₹293.63 Cr for the quarter ended June 30, 2026.
Net Profit remained stagnant at ₹0.88 Cr (₹88 lakhs) compared to the restated ₹0.88 Cr in Q1 FY26.
Total expenses for the quarter rose to ₹298.51 Cr, driven by cost of materials consumed at ₹292.88 Cr.
Earnings Per Share (EPS) for the quarter stood at ₹0.10, a decline from ₹0.18 in the preceding March 2026 quarter.
The company has transitioned to a single primary business segment: Sugar (including distillery) post-demerger.
👀 What to Watch
Investors should monitor the operational efficiency of the now pure-play sugar and distillery business, specifically looking for updates on ethanol production quotas and sugar MSP. The impact of the demerger on the company's debt-to-equity profile (currently 1.17) and working capital cycle needs close observation in upcoming quarters.
Rs 16.59 Cr Income Tax Refund Received by DCM Shriram Industries
DCM Shriram Industries has received an income tax refund amounting to Rs 16.59 crore, including interest, for the financial year ended 2018. This cash inflow is highly material as it represents approximately 118% of the company's TTM PAT of Rs 14 crore. The refund follows the resolution of a tax litigation/dispute and will provide a one-time boost to the company's liquidity and bottom line. Given the company's small market cap of Rs 383 crore, this non-recurring gain is a significant positive event.
Confidence: HIGH
What changedThe company has successfully concluded a tax dispute for FY 2017-18, resulting in a confirmed cash recovery from the tax authorities.
Why it mattersFor a company with relatively thin margins (OPM 5.2%) and a high debt-to-equity ratio (1.17), a cash inflow exceeding its annual profit provides a significant liquidity cushion and improves the immediate balance sheet position.
Income Tax Refund Amount: Rs 16.59 CrRefund vs TTM PAT: ~118.5%Refund vs Market Cap: ~4.3%Relevant Financial Year: 2018
📅 Short termThe news is likely to be viewed positively by the market in the short term due to the substantial size of the refund relative to the company's annual earnings.
📈 Long termLimited structural impact as this is a one-time non-operational gain; the long-term focus remains on the sugar industry cycle and the proposed demerger of Chemical and Rayon businesses.
⚠ Risk flags
- One-off nature of the gain
- Non-operational source of cash
Key Highlights
Received a total Income Tax Refund of Rs 16.59 Crore including interest
The refund pertains to the financial year ended 2018 (FY18)
Refund amount is equivalent to ~118% of the company's TTM Net Profit of Rs 14 Crore
The inflow represents approximately 4.3% of the company's current Market Capitalization of Rs 383 Crore
👀 What to Watch
Investors should look for the inclusion of this refund in the 'Other Income' section of the upcoming quarterly financial results and monitor its impact on the company's debt reduction or working capital.
DCM Shriram Industries Sets July 3 Record Date for ₹0.40 Final Dividend for FY 2025-26
DCM Shriram Industries has recommended a final dividend of ₹0.40 per equity share (20% of face value) for the financial year 2025-26. The company has fixed July 3, 2026, as the record date to determine shareholder eligibility for the payout. The 35th Annual General Meeting (AGM) is scheduled for July 15, 2026, where the dividend will be formally declared. Shareholders must submit relevant tax documents by July 6, 2026, to ensure the application of appropriate TDS rates.
Key Highlights
Recommended a final dividend of ₹0.40 per equity share of face value ₹2 each (20%).
Record date for dividend eligibility is fixed as July 3, 2026.
35th Annual General Meeting (AGM) to be held on July 15, 2026, via video conferencing.
Standard TDS of 10% for resident shareholders with PAN; 20% for those without valid PAN.
No TDS for resident individuals if the total dividend received during FY 2026-27 does not exceed ₹10,000.
👀 What to Watch
Investors interested in the dividend should ensure they hold the stock before the record date of July 3, 2026. Shareholders should also verify that their PAN is updated and submit necessary tax-exemption forms (like Form 15G/15H) by July 6 to avoid higher tax deductions.
DCM Shriram Industries Sets July 3 as Record Date for 20% Dividend (Re 0.40/Share)
DCM Shriram Industries Limited has recommended a dividend of Re 0.40 per equity share of Rs 2 each (20%) for the financial year 2025-26. The company has fixed July 3, 2026, as the record date to identify eligible shareholders for this payout. The dividend is subject to approval at the 35th Annual General Meeting (AGM) scheduled for July 15, 2026. If approved, the payment will be processed by August 13, 2026.
Key Highlights
Dividend of Re 0.40 per equity share (20% of face value) recommended for FY 2025-26.
Record date for dividend eligibility is fixed for July 3, 2026.
35th Annual General Meeting (AGM) to be held on July 15, 2026, via video conferencing.
Dividend payment to be completed within 30 days of the AGM, on or before August 13, 2026.
Sanjay Rastogi appointed as Director & Chief Operating Officer (DSW) effective July 1, 2026.
👀 What to Watch
Investors interested in the dividend must hold the shares in their demat accounts before the record date of July 3, 2026. Monitor the AGM on July 15 for further updates on company performance and management outlook.
DCM Shriram Industries Recommends Re 0.40 Dividend and Announces Management Changes
DCM Shriram Industries has approved its audited financial results for the fiscal year ended March 31, 2026, and recommended a dividend of Re 0.40 per share (20% of face value). The company announced a leadership transition with Sanjay Rastogi appointed as Director & COO and Vineet Manaktala reappointed as CFO. Additionally, the company confirmed the successful implementation of its restructuring scheme, which involved the demerger of the Chemicals and Rayons businesses. These structural and leadership changes are aimed at streamlining operations following the demerger.
Key Highlights
Recommended a dividend of Re 0.40 per equity share (20%) for the financial year 2025-26.
Appointed Sanjay Rastogi as Director & Chief Operating Officer for a 2-year term starting July 1, 2026.
Reappointed Vineet Manaktala as Chief Financial Officer for a one-year term from July 1, 2026.
Confirmed the completion of the demerger of Chemicals and Rayons businesses with a retrospective appointed date of April 1, 2023.
The 35th Annual General Meeting (AGM) is scheduled for July 15, 2026, to finalize these decisions.
👀 What to Watch
Investors should view the dividend and management continuity as positive signs of stability post-restructuring. Monitor the operational performance of the remaining business units following the demerger of the Chemicals and Rayons segments.
DCM Shriram Industries Recommends Re 0.40 Dividend; Appoints Sanjay Rastogi as COO
DCM Shriram Industries has announced a dividend of Re 0.40 per share (20% of face value) for the financial year 2025-26. The board approved the audited financial results for FY26, which incorporate the retrospective effects of the demerger of its Chemicals and Rayon businesses. Key leadership changes include the appointment of Sanjay Rastogi as Director & COO and the reappointment of Vineet Manaktala as CFO. The company’s 35th AGM is set for July 15, 2026, to finalize these proposals.
Key Highlights
Recommended a dividend of Re 0.40 per equity share (20%) for FY 2025-26.
Appointed Sanjay Rastogi as Director & COO (DSW) for a two-year term starting July 1, 2026.
Reappointed Vineet Manaktala as Chief Financial Officer for a one-year term from July 1, 2026.
Financial results account for the demerger of Chemicals and Rayon businesses from April 1, 2023.
35th Annual General Meeting scheduled for July 15, 2026, via video conferencing.
👀 What to Watch
Investors should note the dividend payout and the management transition, which aims to maintain operational stability post-restructuring. Monitor the full financial results for the performance of the remaining business segments.
DCM Shriram Industries Recommends Rs 0.40 Final Dividend and Announces Leadership Changes
DCM Shriram Industries has recommended a final dividend of Rs 0.40 per equity share (20% of face value) for the financial year 2025-26. The company is undergoing a leadership transition with Sanjay Rastogi appointed as Director & COO for two years, while Vineet Manaktala continues as CFO for one year. The Board also approved the audited financial results for the year ended March 31, 2026, which incorporate the retrospective effects of the Chemicals and Rayons business demerger. The 35th Annual General Meeting is scheduled for July 15, 2026, to seek shareholder approval for these items.
Key Highlights
Recommended a final dividend of Rs 0.40 per share (20%) on equity shares of face value Rs 2.
Appointed Sanjay Rastogi as Additional Director and COO for a 2-year term starting July 1, 2026.
Vineet Manaktala reappointed as Chief Financial Officer (CFO) for one year from July 1, 2026.
The 35th Annual General Meeting (AGM) will be held on July 15, 2026, via video conferencing.
Financial results reflect the demerger of Chemicals and Rayons business effective from April 1, 2023.
👀 What to Watch
Monitor the impact of the demerger on the company's simplified balance sheet and focus on the operational efficiency of the sugar business under the new COO. The dividend provides a modest yield for long-term holders.
DCM Shriram Industries Credit Rating Downgraded to CARE A-; Outlook Stable
CARE Edge Ratings has downgraded DCM Shriram Industries' long-term bank facilities and fixed deposits from CARE A+ to CARE A-. The short-term rating was also revised downward from CARE A1+ to CARE A2+. These changes follow the company's performance review for FY25 and the implementation of a Composite Scheme of Arrangement approved by the NCLT. Although the 'Negative Rating Watch' has been removed, the multi-notch downgrade indicates a shift in the company's credit profile.
Key Highlights
Long-term bank facilities downgraded from CARE A+ to CARE A- with a Stable outlook.
Short-term bank facilities lowered from CARE A1+ to CARE A2+.
Fixed deposit rating downgraded to CARE A- from CARE A+.
Ratings removed from 'Rating Watch with Negative implications' post-NCLT scheme approval.
Review based on financial performance for FY 2024-25 and 9M ended Dec 31, 2025.
👀 What to Watch
The downgrade reflects increased credit risk; investors should evaluate the impact of the corporate restructuring on the company's balance sheet. Monitor upcoming quarterly results to see if operational performance can offset the potential for higher borrowing costs.
DCM Shriram Industries: Promoter Urvashi Tilakdhar to Acquire 2.93% Stake
Urvashi Tilakdhar, a member of the promoter group, has filed a disclosure to acquire 25,45,373 shares of DCM Shriram Industries, representing a 2.93% stake. This transaction is an inter-se transfer among promoters, which is typically exempt from open offer requirements under SEBI SAST Regulations. Post-acquisition, the total promoter and PAC (Persons Acting in Concert) holding will increase from 47.18% to 50.11%. This move effectively consolidates majority control within the promoter group.
Key Highlights
Proposed acquisition of 25,45,373 equity shares representing 2.93% of the total share capital.
Promoter and PAC holding to increase from 4,10,44,742 shares (47.18%) to 4,35,90,115 shares (50.11%).
Disclosure filed under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
The transaction represents an internal restructuring/realignment of shares within the promoter group.
👀 What to Watch
This is a routine internal promoter group transaction and does not change the company's fundamental outlook; investors should maintain their current positions.
DCM Shriram Industries Shareholders Approve Key Management Appointments with Over 99% Majority
DCM Shriram Industries Limited has successfully passed four special resolutions through a postal ballot, all receiving over 99.8% shareholder approval. The resolutions confirm the appointments of Mr. Anurag Surana and Mr. Sidharth Prasad as Independent Directors, along with Mr. Uday Shriram as Deputy Managing Director and Mr. Rohan Shriram as Whole Time Director. Total voting participation stood at approximately 59.08% of the total shares, representing 51,397,080 votes. These appointments solidify the company's leadership team and governance framework for the upcoming term.
Key Highlights
Appointment of Mr. Uday Shriram as Deputy Managing Director approved with 99.89% votes in favour.
Mr. Rohan Shriram appointed as Whole Time Director with 99.89% shareholder support.
Independent Directors Anurag Surana and Sidharth Prasad secured 99.89% and 99.96% approval respectively.
Total voter turnout for the postal ballot was 51,397,080 shares, representing 59.08% of total capital.
👀 What to Watch
The high approval ratings indicate strong shareholder confidence in the current management and proposed leadership. Investors should view this as a positive sign of leadership continuity and governance stability.
DCM Shriram Industries Clarifies Non-Submission of Consolidated Q3 FY26 Results
DCM Shriram Industries has clarified to the Exchange that it did not submit consolidated financial results for the quarter ended December 31, 2025, because it no longer has any subsidiaries or associates. This change is the result of a court-approved Scheme of Arrangement that became effective on December 17, 2025, demerging two business segments into independent entities. Consequently, former subsidiaries like DCM Shriram Fine Chemicals and DCM Shriram International have ceased to be part of the company's consolidated group. Investors should now view the company's financial performance on a standalone basis following this structural reorganization.
Key Highlights
Scheme of Arrangement became effective on December 17, 2025, after NCLT approval and ROC filing.
Two business segments were demerged into DCM Shriram Fine Chemicals Ltd and DCM Shriram International Ltd.
The company reported having zero subsidiaries, associates, or joint ventures as of the December 31, 2025 reporting date.
Consolidated financial statements are no longer applicable for the company following the restructuring.
The restructuring was effective retrospectively from April 1, 2023, for accounting purposes.
👀 What to Watch
Investors should update their valuation models to reflect the company's new standalone structure and monitor the separate listing or performance of the demerged entities. No further consolidated reporting should be expected unless new subsidiaries are formed or acquired.
DCM Shriram Industries Q3 Net Profit Flat at ₹3.47 Cr Post-Demerger of Chemical & Rayon Units
DCM Shriram Industries reported a marginal increase in net profit to ₹3.47 crore for Q3 FY26, compared to ₹3.45 crore in the restated year-ago period. Revenue from operations saw a slight dip to ₹254.37 crore from ₹261.19 crore. The quarter was significant for the completion of a major corporate restructuring involving the demerger of the Chemical and Rayon businesses and the amalgamation of Lily Commercial Private Limited. Consequently, all historical figures have been restated to reflect only the continuing operations.
Key Highlights
Q3 FY26 Net Profit stood at ₹3.47 crore, nearly flat compared to ₹3.45 crore in Q3 FY25 (restated).
Revenue from operations for the quarter was ₹254.37 crore, a 2.6% decline from ₹261.19 crore YoY.
9M FY26 Net Profit reached ₹10.46 crore on a total income of ₹845.07 crore.
Demerger of Chemical and Rayon businesses finalized with an effective date of December 17, 2025, and retrospective accounting from April 1, 2023.
Amalgamation of Lily Commercial Private Limited completed, involving the cancellation and re-allotment of 50.11% of the company's equity shares to Lily's shareholders.
👀 What to Watch
Investors should evaluate the company based on the restated financials as the demerger has significantly altered the business profile and asset base. Monitor the performance of the remaining core segments, primarily Sugar, to assess growth potential in the new leaner corporate structure.
DCM Shriram Industries Sets Cost Apportionment Ratio for Demerged Entities
DCM Shriram Industries has announced the cost of acquisition apportionment for its shareholders following the demerger of its Chemical and Rayon undertakings. For every 1 equity share held in the parent company, shareholders have been allotted 1 share each in DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited. The cost of acquisition for the original shares will now be split among the three entities based on specific percentages for tax purposes. This update follows the scheme of arrangement that became effective on December 17, 2025.
Key Highlights
Cost of acquisition for DCM Shriram Industries Limited (Parent) is set at 42.66%
Cost of acquisition for DCM Shriram Fine Chemicals Limited is set at 25.22%
Cost of acquisition for DCM Shriram International Limited is set at 32.12%
Share entitlement ratio is 1:1:1 for the parent and the two resulting companies
The apportionment is based on the net book value of assets transferred as of the demerger date
👀 What to Watch
Shareholders should use these ratios to adjust their purchase price records for tax compliance and capital gains calculations. No immediate action is required regarding the holding of the shares themselves.
DCM Shriram Industries Proposes Appointment of 4 Directors; E-voting Starts Jan 26
DCM Shriram Industries has issued a postal ballot notice to seek shareholder approval for four key board appointments. This includes two Independent Directors, Mr. Anurag Surana and Mr. Sidharth Prasad, for five-year terms ending in December 2030. Additionally, the company is seeking approval for Mr. Uday Shriram as Deputy Managing Director and Mr. Rohan Shriram as Whole Time Director, both for five-year terms starting December 23, 2025. The e-voting process is scheduled to run from January 26 to February 24, 2026.
Key Highlights
Appointment of two Independent Directors for 5-year terms ending December 9, 2030.
Mr. Uday Shriram and Mr. Rohan Shriram proposed for executive roles for 5-year terms from Dec 23, 2025.
Remote e-voting period scheduled from Jan 26, 2026, to Feb 24, 2026.
All four resolutions are proposed as Special Resolutions requiring 75% majority approval.
The cut-off date for determining shareholder voting eligibility was January 19, 2026.
👀 What to Watch
Investors should review the professional backgrounds of the proposed directors to ensure leadership alignment with the company's growth strategy. No immediate portfolio action is required as these are standard governance procedures.
DCM Shriram Industries Completes Share Allotment for Demerger; Effective Date Dec 17, 2025
DCM Shriram Industries has finalized the allotment and credit of equity shares for its two resulting companies, DCM Shriram Fine Chemicals and DCM Shriram International, under a composite scheme of arrangement. The effective date of the scheme is confirmed as December 17, 2025, following the filing of NCLT orders. As a result, these entities have ceased to be subsidiaries and are now independent companies. Both resulting companies are currently seeking listing and trading permissions from the BSE and NSE to provide liquidity to shareholders.
Key Highlights
Effective date of the demerger scheme confirmed as December 17, 2025.
Shares of DCM Shriram Fine Chemicals and DCM Shriram International credited to eligible shareholders.
Resulting companies have ceased to be wholly-owned subsidiaries of DCM Shriram Industries.
Listing applications for the new entities are being processed with BSE and NSE.
Pre-scheme share capital of the resulting companies held by the parent has been cancelled.
👀 What to Watch
Shareholders should verify the credit of new shares in their demat accounts and monitor upcoming exchange notifications for the listing dates of the two new entities.
DCM Shriram Industries Reconstitutes Board; Appoints New MD & CEO with Remuneration Hike
DCM Shriram Industries has announced a major board reconstitution following an NCLT-approved Scheme of Arrangement. Mr. Alok Bansidhar Shriram has resigned as Sr. MD & CEO, and Mr. Madhav Bansidhar Shriram has been redesignated as MD & CEO with a basic salary hike from Rs. 5.8 lakh to Rs. 7.5 lakh per month. Additionally, two new executive directors, Mr. Uday Shriram and Mr. Rohan Shriram, have been inducted to lead the restructured entity. The changes are part of a broader corporate reorganization involving the creation of two new resultant companies.
Key Highlights
Resignation of Mr. Alok Bansidhar Shriram (Sr. MD & CEO) and Mrs. Urvashi Tilakdhar (WTD) effective Dec 23, 2025.
Mr. Madhav Bansidhar Shriram redesignated as MD & CEO with basic salary increased to Rs. 7.5 lakh per month.
MD & CEO commission increased from up to 3% of PBT to up to 5% of PBT effective FY 2025-26.
Induction of Mr. Uday Shriram as Dy. Managing Director and Mr. Rohan Shriram as Whole Time Director.
Board changes implemented to facilitate the NCLT-approved Scheme of Arrangement involving three distinct corporate entities.
👀 What to Watch
Investors should track the operational transition as the company implements its Scheme of Arrangement and monitor the performance of the new leadership team. The significant increase in MD remuneration and the induction of next-generation promoters suggest a long-term leadership transition.
DCM Shriram Industries Revises Record Date to Dec 26 for 1:1 Demerger Allotment
DCM Shriram Industries has announced a revision in the record date for its Composite Scheme of Arrangement to December 26, 2025, from the previous date of December 19. Under the scheme, eligible shareholders will receive one equity share each in two new entities, DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited, for every one share held in the parent company. The delay is due to administrative formalities regarding the extinguishment and allotment of shares for a transferor company. The new shares are expected to be listed on the BSE and NSE within 45-60 days after the necessary applications are filed.
Key Highlights
Revised Record Date for the demerger entitlement is now Friday, December 26, 2025.
Share entitlement ratio fixed at 1:1 for both DCM Shriram Fine Chemicals and DCM Shriram International.
All shares involved in the transaction have a face value of INR 2 per share.
Listing of the two new resultant companies is estimated to take 45-60 days post-allotment.
The delay was caused by formalities related to the transferor company, Lily Commercial Private Limited.
👀 What to Watch
Investors must hold DCMSRIND shares until the revised record date of December 26 to qualify for the new shares. Be prepared for a temporary lack of liquidity in the demerged entities for approximately two months until listing is completed.
DCM Shriram Industries Revises Record Date for Demerger to December 26, 2025
DCM Shriram Industries Limited has announced a revision in the record date for its corporate restructuring plan from December 19 to December 26, 2025. This restructuring involves the allotment of shares in two new entities: DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited. The delay is attributed to administrative formalities regarding the extinguishment and allotment of shares involving Lily Commercial Pvt. Limited. Shareholders holding the stock as of the new record date will be eligible for the share allotment in the resultant companies.
Key Highlights
Revised Record Date for the Scheme of Arrangement is now December 26, 2025.
The previous record date was set for December 19, 2025.
Entitlement includes shares in two new entities: DCM Shriram Fine Chemicals and DCM Shriram International.
Delay caused by pending formalities related to the transferor company, Lily Commercial Pvt. Limited.
👀 What to Watch
Investors interested in receiving shares of the two demerged entities must ensure they hold the stock until the revised record date of December 26, 2025. No immediate action is required other than noting the one-week delay in the process.
DCM Shriram Industries Sets Dec 19 Record Date for 1:1:1 Demerger into Three Entities
DCM Shriram Industries (DCMSR) has announced December 19, 2025, as the record date for its composite scheme of arrangement. Under the scheme, the company is demerging its Chemicals and Rayon businesses into two separate entities: DCM Shriram Fine Chemicals and DCM Shriram International. Eligible shareholders will receive 1 share of each new entity for every 1 share held in DCMSR, effectively splitting the conglomerate into three distinct listed companies focusing on Sugar, Chemicals, and Rayon respectively.
Key Highlights
Record date for share entitlement fixed as Friday, December 19, 2025.
Shareholders to receive 1 share of DSFCL and 1 share of DSIL for every 1 share of DCMSR held.
Chemicals business demerged into DSFCL and Rayon business demerged into DSIL.
DCMSR will retain the Sugar business, including power and alcohol undertakings.
Both new entities (DSFCL and DSIL) will be listed on BSE and NSE following the allotment.
👀 What to Watch
Investors seeking to participate in the value unlocking should ensure they hold shares before the record date of December 19. Be prepared for a significant price adjustment in DCMSR stock on the record date as the value of the demerged businesses is separated.
DCM Shriram Industries: Record Date for Scheme of Arrangement is 19-Dec-2025
DCM Shriram Industries Limited announced a record date of December 19, 2025, for the Composite Scheme of Arrangement. Shareholders will receive one fully paid-up share of ₹2 in each of the two resultant companies, DCM Shriram Fine Chemicals (DSFCL) and DCM Shriram International Limited (DSIL), for every share held in DCM Shriram Industries. The equity shares of each Resultant Companies will be issued to the shareholders of DCM Shriram Industries Limited (DCMSR) in the ratio of 1:1. This follows the NCLT's sanction of the scheme involving Lily Commercial Private Limited, DCM Shriram Fine Chemicals Limited, and DCM Shriram International Limited.
Key Highlights
Record date is 19-Dec-2025 for the Composite Scheme of Arrangement.
Shareholders receive one share in each of DSFCL and DSIL for every share in DCM Shriram Industries.
Equity Shares of each Resultant Companies will be issued to the shareholders of DCM Shriram Industries Limited (DCMSR) in the ratio of 1:1.
Scheme involves Lily Commercial Private Limited, DCM Shriram Fine Chemicals Limited, and DCM Shriram International Limited.
👀 What to Watch
Shareholders should note the record date of December 19, 2025, to be eligible for the share allocation in DCM Shriram Fine Chemicals and DCM Shriram International. Monitor further announcements regarding the scheme's effectiveness after filing with the Registrar of Companies.
